Peer-Reviewed Papers
Trial Analysis
Benefit-risk balance of S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)
READ MORE →
Peer-Reviewed Papers
Generalized Pairwise Comparisons to Support Shared Decision-Making in the CODA Trial
READ MORE →
Trial Designs
OSE Immunotherapeutics: One2Treat Voice for outcomes prioritization in ARTEMIA
READ MORE →
Trial Designs
Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores
READ MORE →
Methodological papers
On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes
READ MORE →
Best Practices
Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week
READ MORE →
Trial Analysis
Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
READ MORE →
Trial Designs
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen
READ MORE →
Methodological papers
Generalized pairwise comparisons of prioritized outcomes in the two-sample problem
READ MORE →
Methodological papers
Generalized pairwise comparison methods to analyse (non)prioritized composite endpoints
READ MORE →
Methodological papers
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: a simulation study
READ MORE →
Methodological papers
The asymptotic distribution of the net benefit estimator in the presence of censoring
READ MORE →